Search For "biosimilars"
Tata Capital to pick minority stake in Biocon Biologics for Rs 225 cr
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], July 31 (ANI): Private equity major Tata Capital Growth Fund will pick up 0.85 per cent stake in the biologics arm of biopharmaceutical major Biocon for Rs 225 crore.
Read More
Biocon stock falls 2 pc after 28 pc fall in Q1 net profit
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Shares of Biocon Ltd fell by nearly 2 per cent on Friday morning after the biopharmaceutical major posted 28 per cent fall in its June quarter (Q1 FY21) net profit at Rs 149 crore.
Read More
Biocon Biologics and Voluntis join hands for global collaboration on dig
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], July 21 (ANI): Biocon Biologics India Limited, a fully integrated 'pure-play' biosimilars company, a subsidiary of Biocon Ltd. on Tuesday announced a global collaboration agreement between Biocon Biologics' subsidiary Biocon Sdn. Bhd., Malaysia and Voluntis to
Read More
Biocon Biologics appoints M B Chinappa as new CFO
Updated : 6 years, 2 months ago IST
Bengaluru (Karnataka) [India], Jan 7 (ANI): Biocon Ltd has appointed M B Chinappa as the Chief Financial Officer of its subsidiary Biocon Biologics India Ltd.
Read More
True North to invest Rs 536 crore in Biocon Biologics for 2.4 pc stake
Updated : 6 years, 2 months ago IST
Bengaluru (Karnataka) [India], Jan 6 (ANI): Biopharmaceuticals major Biocon said on Monday the board of its subsidiary Biocon Biologics has approved a primary equity investment by True North which will invest Rs 536.25 crore to pick 2.44 per cent minority stake in the biosimilars business.
Read More
Biocon's Biologics drug products facility gets nod from US FDA
Updated : 6 years, 4 months ago IST
Bengaluru (Karnataka) [India], Nov 5 (ANI): Biopharmaceuticals major Biocon Ltd said on Tuesday it has received an establishment inspection report from the US Food and Drug Administration (FDA) for its biologics drug product facility here, reaffirming its global scale manufacturing capabilit
Read More
Biocon Biologics expands R&D footprint by acquiring assets of Pfizer Healt
Updated : 6 years, 5 months ago IST
Bengaluru (Karnataka) [India], Sep 24 (ANI): Biopharmaceuticals major Biocon Ltd said on Tuesday that its subsidiary has acquired research and development capital assets from Pfizer Healthcare India Ltd.
Read More